138
Views
2
CrossRef citations to date
0
Altmetric
OVARIAN HYPERSTIMULATION SYNDROME: LIFESAVING DOSE INCREMENT OF CABERGOLINE

Lifesaving dose increment of cabergoline in life-threatening spontaneous ovarian hyperstimulation syndrome resistant to all interventions

, , , , &
Pages 287-289 | Received 15 Jul 2018, Accepted 16 Sep 2018, Published online: 18 Dec 2018

References

  • Gil Navarro N, Garcia Grau E, Pina Pérez S, et al. Ovarian torsion and spontaneous ovarian hyperstimulation syndrome in a twin pregnancy: a case report. Int J Surg Case Rep. 2017;34:66–68.
  • Kanza RE, Gagnon S, Villeneuve H, et al. Spontaneous ovarian hyperstimulation syndrome and pituitary hyperplasia mimicking macroadenoma associated with primary hypothyroidism. Wjr. 2013;5:20–24.
  • Sridev S, Barathan S. Case report on spontaneous ovarian hyperstimulation syndrome following natural conception associated with primary hypothyroidism. J Hum Reprod Sci. 2013;6:158–161.
  • Mittal K, Koticha R, Dey AK, et al. Radiological illustration of spontaneous ovarian hyperstimulation syndrome. Pol J Radiol. 2015;28:217–227.
  • Montanelli L, Delbaere A, Di Carlo C, et al. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. 2004;89:1255–1258.
  • Di Carlo C, Savoia F, Fabozzi A, et al. A case of ovarian torsionin a patient carrier of a FSH receptor gene mutation previously affected by spontaneous ovarian hyperstimulation syndrome. Gynecol. Endocrinol. 2015;31:105–108.
  • Munshi S, Patel A, Banker M, et al. Laparoscopic detorsion for bilateral ovarian torsion in a singleton pregnancy with spontaneous ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2014;7:66–68.
  • Lussiana C, Guani B, Restagno G, et al. Ovarian hyperstimulation syndrome after spontaneous conception. Gynecol Endocrinol. 2009;25:455–459.
  • Ahmed Kamel RM. Spontaneous ovarian hyperstimulation syndrome in a naturally conceived singleton pregnancy. Fertil Steril. 2010;94:5.
  • Şafak H. Servet Gençdal2, Melahat Atasever3, Emre Ekmekçi4, Murat Bakacak5, Sefa Kelekçi4 Evaluation of polycystic ovary syndrome patients treated for OHSS. J Infertility Rep Biol. 2015;3:179–183.
  • Papaleo E, Doldi N, De S, et al. Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome. Hum Reprod. 2001;16:2263–2266.
  • Alvarez C, Alonso-Muriel I, Garcia G, et al. Implantiation is apparently unaffected by the dopamine agonist cobergoline when administerred to prevent ovarian hyperstimulation syndrome in women undergoing assited reproduction treatment: a pilot study. Hum Reprod. 2007;22:3210–3214.
  • Alvarez C, Marti b. L, Novella- Maestre E, et al. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab. 2007;92:2931–2937.
  • Baumgarten M, Polanski L, Campbell B, et al. Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis. Hum Fertil (Camb). 2013;16:168–174.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.